Compare FNKO & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FNKO | MOBI |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.5M | 383.0M |
| IPO Year | 2017 | 2026 |
| Metric | FNKO | MOBI |
|---|---|---|
| Price | $6.51 | $11.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $7.25 | ★ $17.75 |
| AVG Volume (30 Days) | ★ 801.3K | 162.3K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $908,209,000.00 | N/A |
| Revenue This Year | $2.98 | $71.88 |
| Revenue Next Year | $8.18 | $43.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.72 | $8.03 |
| 52 Week High | $7.35 | $15.19 |
| Indicator | FNKO | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 67.62 |
| Support Level | $5.13 | $11.25 |
| Resistance Level | $6.58 | $11.55 |
| Average True Range (ATR) | 0.27 | 0.56 |
| MACD | 0.01 | 0.37 |
| Stochastic Oscillator | 47.01 | 97.60 |
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.